Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$799,174
in 9 filings, $788K under 10b5-1 plans

Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-02-05 Hanley Kevin F. Senior V.P.,Tech Operations Grant or award · Stock Option (Right to Buy) +125,000 125,000
2018-01-31 Goldstein Michael H. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +83,500 83,500
2018-01-31 Bollag Daniel M Grant or award · Stock Option (Right to Buy) +51,100 51,100
2018-01-31 Notman Donald Chief Financial Officer Grant or award · Stock Option (Right to Buy) +83,500 83,500
2018-01-31 Mattessich Antony C. President and CEO Grant or award · Stock Option (Right to Buy) +360,000 360,000
2018-01-31 Sawhney Amarpreet Exec Chairman of the Board Grant or award · Stock Option (Right to Buy) +130,000 130,000
2017-12-21 Sawhney Amarpreet Exec Chairman of the Board Exercise or conversion +83,011 $2.49 $207K 779,401
2017-12-21 Sawhney Amarpreet Exec Chairman of the Board Exercise or conversion +106,382 $2.73 $290K 885,783
2017-12-21 Sawhney Amarpreet Exec Chairman of the Board Exercise or conversion · Stock Option (Right to Buy) −83,011 0
2017-12-21 Sawhney Amarpreet Exec Chairman of the Board Exercise or conversion · Stock Option (Right to Buy) −106,382 0
2017-12-12 Mattessich Antony C. President and C.E.O. Purchase +21,000 $4.29 $90K 21,000
2017-12-07 Notman Donald Chief Financial Officer Purchase +4,800 $4.00 $19K 4,800
2017-12-06 Bollag Daniel M Purchase +24,700 $3.93 $97K 24,700
2017-11-16 Sawhney Amarpreet Exec. Chairman of the Board Purchase +19,000 $5.18 $98K 696,390
2017-10-02 Goldstein Michael H. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +135,000 135,000
2017-10-02 Notman Donald Chief Financial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2017-08-07 Bollag Daniel M Grant or award · Stock Option (Right to Buy) +110,000 110,000
2017-06-20 Mattessich Antony C. Director Grant or award · Stock Option (Right to Buy) +590,000 590,000
2017-06-01 GARVEY JAMES M Director Grant or award · Stock Option (Right to Buy) +13,500 13,500
2017-06-01 Chadha Jaswinder Director Grant or award · Stock Option (Right to Buy) +13,500 13,500

Page 19 of 27 · 522 trades